Blog
RSS FeedPosted by Michael Wonder on 28 Jun 2017
New strategy from PHARMAC to help Pacific communities in New Zealand
28 June 2017 - The New Zealand drug buying agency PHARMAC has released the Pacific Responsiveness Strategy after a year of ...
Posted by Michael Wonder on 26 Jun 2017
'Win-win' as PHARMAC drops restrictions on HIV medication
23 June 2017 - PHARMAC is ditching a policy that required New Zealanders diagnosed with HIV to reach a threshold of ...
Posted by Michael Wonder on 15 Jun 2017
Cancer patients, children, and people with HIV amongst those to benefit from PHARMAC decisions
15 June 2017 - PHARMAC has announced the funding of five new treatments and wider use of over 30 existing ...
Posted by Michael Wonder on 15 Jun 2017
Bendamustine funding approved
15 June 2017 - PHARMAC is pleased to announce the approval of an agreement with Janssen-Cilag for the listing of ...
Posted by Michael Wonder on 13 Jun 2017
Decision relating to various oncology medicines
13 June 2017 - PHARMAC is pleased to announce the approval of proposals for various oncology pharmaceuticals, including new listings ...
Posted by Michael Wonder on 12 Jun 2017
Proposal for various medicines in the neurology, immunology and nephrology therapeutic areas approved
12 June 2017 - PHARMAC is pleased to announce the approval of a proposal relating to certain medicines in the ...
Posted by Michael Wonder on 31 May 2017
New Zealand Pharmaceutical Schedule - 1 June 2017
1 June 2017 - The June 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 May 2017
National MP urges PHARMAC to consider 'gold standard' neuroendocrine cancer treatment
30 May 2017 - A National MP and chair of Parliament's health committee says it's important PHARMAC consider funding a ...
Posted by Michael Wonder on 25 May 2017
New medicines funding for breast cancer still elusive
25 May 2017 - The Breast Cancer Aotearoa Coalition (BCAC) welcomes new funding for the Government’s drug-buying agency, PHARMAC, but ...
Posted by Michael Wonder on 23 May 2017
Neuroendocrine cancer sufferers take on PHARMAC
20 May 2017 - Jess Spence hurried in from the rain having just finished yoga class. ...
Posted by Michael Wonder on 15 May 2017
Proposal to list bendamustine hydrochloride
15 May 2017 - PHARMAC is seeking feedback on a proposal to list bendamustine hydrochloride (Ribomustin) through a provisional agreement ...
Posted by Michael Wonder on 10 May 2017
Hepatitis C drug could avert liver transplants - doctors
10 May 2017 - Hepatitis C sufferers say a highly-expensive drug PHARMAC is considering offering to more patients has "given them ...
Posted by Michael Wonder on 09 May 2017
Patient voice prompts new medicines funding
7 May 2017 - Medicines New Zealand is pleased that the New Zealand Government has today announced an additional investment ...
Posted by Michael Wonder on 08 May 2017
Southern Cross launches cover for cancer drugs not funded by PHARMAC
8 May 2017 - The frightening cost of non-PHARMAC funded cancer treatments has prompted the country's largest health insurer to ...
Posted by Michael Wonder on 08 May 2017
HIV treatment proposal welcomed by New Zealand AIDS Foundation
8 May 2017 - The proposal to fund earlier access to HIV drugs has been welcomed by the New Zealand ...